02 October,2020 12:00 PM IST | Mumbai | mid-day online correspondent
This picture has been used for representational purpose only
Mumbai's Crime Branch unit on Wednesday arrested a chemist from Delhi's Govindpuri Colony for allegedly making fake Tocilizumab, a drug used in the treatment of COVID-19. Police officials said they were investigating a case in which they seized 15 vials of the drug.
Also Read: Drug peddler arrested with MD worth Rs 14.40 lakh from Goregaon
According to a report in Mumbai Mirror, the police were inquiring into a case wherein they had seized 15 injections of Tocilizumab. Senior inspector Nandkumar Gopale, Crime Branch (Unit IX), said, "We were investigating this gang, which was overpricing the injection."
After the seizure, police officials sent some samples to Rosh Products India Private Limited, the authorised distributor in India of the injection, which is manufactured in Switzerland. The distributor confirmed that the injections were fake. Later, the accusedwas taken into custody.
ALSO READ
Police launch operation to nab prisoners released during Covid-19, 18 held
Thane reports 191 new Covid-19 cases, 2 deaths
Mumbai Crime: Burglar tied to bed flees Kasturba Hospital, held within 24 hours
Mumbai: Case filed against 103-year-old under Domestic Violence Act
IPL 2022: Two drunk cops breach bio-bubble to click pictures with players
Read the l atest crime stories in Mumbai and rest of India
"The accused took one original injection and later ordered a Uttarakhand company to make same bottles. He used to fill asthma medicine Dexona and Deriphyllin along with distilled water in the injection and label it as Tocilizumab," SI Gopale added.
The Crime Branch authorities are trying to establish the number of injections the accused has circulated in the market, he said.
Catch up on all the latest Crime, National, International and Hatke news here. Also download the new mid-day Android and iOS apps to get latest updates.
Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news